Surat Samachar

DelveInsight Business Research LLP

DelveInsight’s “Chronic Fatigue Syndrome Market Insights, Epidemiology, and Market Forecast-2032“ report delivers an in-depth understanding of the Chronic Fatigue Syndrome, historical and forecasted epidemiology as well as the Chronic Fatigue Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Chronic Fatigue Syndrome Overview

Chronic Fatigue Syndrome (ME/CFS) is a chronic, debilitating multi-system illness affecting the neurological, endocrine, and immune systems characterized by profound fatigue, sleep abnormalities, pain and other symptoms that are made worse by exertion. It is suspected that the diseases is caused by a change in the immune system of the person and the way the patient responds to infection or stress, viral infection, psychological stress, genetics or a combination of factors. ME/CFS shares some features of autoimmune illnesses as well. Symptoms may appear similar to other illnesses and there is no test to confirm ME/CFS, making it difficult to diagnose. The illness can be unpredictable. Symptoms come and go, or there may be changes in the severity over time. Primary symptoms include highly reduced ability to do activities that were usual before the illness. This drop in activity level occurs along with fatigue and lasts for six months or longer, with worsening of symptoms after physical or mental activity that would not have caused a problem before illness known as post-exertional malaise (PEM) and sleep problems.

 Chronic Fatigue Syndrome Epidemiology Insights:

• According to a major study conducted by Valdez et al. (2019) in a study titled “Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning”, the frequency of diagnosis of ME/CFS was 519–1,038/1,00,000 and among theses diagnosed patients 35-40% were men. Additionally, the study also highlighted the fact that  the number of patients who may be diagnosed with the disease in the US is approximately 1.7 million to 3.38 million.

• The Centers for Disease Control and Prevention (CDC) conducted a ME/CFS surveillance study and estimated that between 8,36,000 and 2.5 million Americans have been estimated to have ME/CFS. However, among these identified cases, less than 20% received a proper ME/CFS diagnosis and among persons diagnosed with the condition, the ratio of women to men can be as high as 4 to 1. Moreover, the study mentioned that the disease is less common in children than in adults, and it is more prevalent in adolescents than in younger children. It is most common in people between 40 and 60 years old.

 Click here to learn more about Chronic Fatigue Syndrome Market Landscape

The Report Covers the Chronic Fatigue Syndrome Epidemiology Segmented by –

• Chronic Fatigue Syndrome total prevalent cases 

• Chronic Fatigue Syndrome gender specific prevelant cases 

• Chronic Fatigue Syndrome age specific prevelant cases 

• Chronic Fatigue Syndrome treated cases 

• Chronic Fatigue Syndrome diagnosed cases 

Chronic Fatigue Syndrome Market Outlook 

The Chronic Fatigue Syndrome market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Chronic Fatigue Syndrome market trends by analyzing the impact of current Chronic Fatigue Syndrome therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Chronic Fatigue Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Chronic Fatigue Syndrome market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Chronic Fatigue Syndrome market in 7MM is expected to witness a major change in the study period 2019-2032.

 Key Companies in the Chronic Fatigue Syndrome Market Include:

• AIM Immuno Technology 

• Cortene Therapeutics 

• NL5 Pharmaceuticals 

And many more 

Chronic Fatigue Syndrome Therapies Covered in the Report Include:

• Ampligen 

• CT38

• NLS-4 (Lauflumide)

And many others

Learn more about the Key Companies and the Emerging Therapies in the Chronic Fatigue Syndrome Market

Table of Contents 

1. Key Insights 

2. Report Introduction 

3. Executive Summary of Chronic Fatigue Syndrome  

4. Disease Background and Overview

5. Epidemiology and patient population

6. Chronic Fatigue Syndrome Emerging Therapies

7. Chronic Fatigue Syndrome Market Outlook

8. Market Access and Reimbursement of Therapies

9. Market Drivers 

10. Market Barriers 

11. Appendix

12. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

Click here to read more about the report’s offerings @ Chronic Fatigue Syndrome Market Outlook 

Related Reports 

Chronic Fatigue Syndrome Pipeline Insights

Chronic Fatigue Syndrome Pipeline Insight, 2023″ report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) market. A detailed picture of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) pipeline landscape is provided, which includes the disease overview and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) treatment guidelines

Trending Reports by DelveInsight

• Adalimumab Biosimilar Market

• Arbovirus Infection Market

• Artificial Pancreas Device System Market

• Dental Equipment Market

• Gluten Sensitivity Market

• Hypothyroidism Market

• Inflammatory Bowel Disease Market

• Mayus Kinase Jak Inhibitors Market

• Mild Dry Eye Market

• Mucopolysaccharidosis Market

• Oncolytic Virus Cancer Therapy Market

• Pyoderma Gangrenosum Market

• Transdermal Drug Delivery Devices Market

• Intrathecal Pumps Market

• Hedgehog Pathway Inhibitors Market

• Yellow Fever Market

• Laryngeal Cancer Market

• Female Infertility Market

• Gender Dysphoria Market

• Chronic Brain Damage Market

• Spain Healthcare Outlook Market

• Malignant Fibrous Histiocytoma Market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services